Digestives & Intestinal Remedies - Ghana

Ghana

Highlights

In Ghana, the Digestives & Intestinal Remedies market market generated a revenue of US$15.11m in 2024.
It is projected to experience an annual growth rate of 4.72% (CAGR 2024-2029).
When compared globally, China leads the market with a revenue of US$4.41bn in 2024.
In terms of per capita revenue, each person in Ghana generated US$0.43 in 2024.
Ghana is experiencing a growing demand for digestive and intestinal remedies in its OTC pharmaceutical market.

Key regions:

Market definitionIn-Scope/Out-of-scopeMarket structureReportsMethodology

The Digestives & Intestinal Remedies market in Ghana has been experiencing steady growth in recent years. Customer preferences for natural and herbal remedies, along with an increasing awareness of digestive health, have contributed to this growth. Additionally, local special circumstances and underlying macroeconomic factors have played a role in shaping the market.Customer preferences in Ghana have shifted towards natural and herbal remedies for digestive issues. Ghanaians have a long history of using traditional herbal medicines for various ailments, including digestive problems. This preference for natural remedies has translated into a demand for herbal digestive supplements and remedies. Consumers are increasingly seeking products that are derived from natural sources and have fewer side effects compared to synthetic alternatives.Another customer preference driving the market is the growing awareness of digestive health. Ghanaians are becoming more conscious of the impact of their diet and lifestyle on their digestive system. As a result, there is a growing demand for products that promote digestive health, such as probiotics and fiber supplements. Consumers are seeking products that can alleviate common digestive issues such as indigestion, bloating, and constipation.Trends in the Digestives & Intestinal Remedies market in Ghana are aligned with global and regional market trends. The market is witnessing a shift towards personalized and preventive healthcare. Consumers are increasingly taking a proactive approach to their health and are willing to invest in products that can prevent or manage health issues. This trend is driving the demand for digestive supplements and remedies that promote overall gut health.Local special circumstances in Ghana have also influenced the development of the Digestives & Intestinal Remedies market. The country has a rich tradition of herbal medicine, and many Ghanaians prefer to use traditional remedies for their health needs. This has created a niche market for herbal digestive supplements and remedies. Local manufacturers have capitalized on this demand by producing herbal products that cater to the specific needs and preferences of Ghanaian consumers.Underlying macroeconomic factors have also played a role in shaping the market. Ghana's economy has been growing steadily in recent years, leading to an increase in disposable income. This has allowed consumers to spend more on healthcare products, including digestive remedies. Additionally, the government's focus on improving healthcare infrastructure and access to healthcare services has created a favorable environment for the growth of the Digestives & Intestinal Remedies market.In conclusion, the Digestives & Intestinal Remedies market in Ghana is developing due to customer preferences for natural and herbal remedies, an increasing awareness of digestive health, local special circumstances related to traditional herbal medicine, and underlying macroeconomic factors such as growing disposable income and government investment in healthcare. These factors have created a favorable environment for the growth of the market, with consumers seeking personalized and preventive healthcare solutions for their digestive health needs.

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.